HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro
In this episode, we are privileged to host two outstanding healthcare leaders who can help us learn a new way of managing painful diabetic neuropathy. Niamh Pellegrini is the Chief Commercial Officer at Nevro, and Meredith Vornholt is the Senior Director.
Niamh and Meredith discuss HFX for PDN and how it can help patients suffering from painful diabetic neuropathy. They share insights on leveraging technology to help patient care, employer impact, challenges, patient anecdotes, and much more.
HFX for PDN is the only spinal cord stimulation device approved by the FDA with a specific indication to treat PDN.
Learn more about this innovative treatment in this exciting episode of the Outcomes Rocket podcast, so please tune in!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
